BioMarin Pharmaceutical
BMRN
#1886
Rank
A$15.73 B
Marketcap
A$81.23
Share price
-0.16%
Change (1 day)
0.21%
Change (1 year)

EPS for BioMarin Pharmaceutical (BMRN)

EPS in 2023 (TTM): A$1.18

According to BioMarin Pharmaceutical's latest financial reports the company's current EPS (TTM) is A$0.55. In 2022 the company made an earnings per share (EPS) of A$1.11 an increase over its 2021 EPS that were of A-$0.51.

EPS history for BioMarin Pharmaceutical from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A$1.185.72%
2022A$1.11-319.62%
2021A-$0.51-107.38%
2020A$6.87-3485.71%
2019A-$0.20-67.44%
2018A-$0.62-34.85%
2017A-$0.96-83.21%
2016A-$5.70263.89%
2015A-$1.5718.68%
2014A-$1.32-28.91%
2013A-$1.8634.74%
2012A-$1.3893.88%
2011A-$0.71-124.5%
2010A$2.90
2009N/A-100%
2008A$0.46-300%
2007A-$0.23-54.29%
2006A-$0.51-67.89%
2005A-$1.58-62.54%
2004A-$4.22136.59%
2003A-$1.78-15.17%
2002A-$2.10-11.59%
2001A-$2.3856.19%
2000A-$1.5210.53%
1999A-$1.38

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
A$2.76 400.77%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
A-$8.47-1,636.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
A-$0.55-200.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A-$0.02899-105.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A-$0.16-128.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
A$2.62 376.32%๐Ÿ‡บ๐Ÿ‡ธ USA